Finance

Lists
Why is PRE down 14.65%?
Dive Deeper
PRE:NASDAQ
Prenetics Global Ltd
$8.80
-14.65%
(-1.51) 1D
$8.97
+1.93% (+0.17)
After hours
Closed: Nov 20, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRE...
Open
$10.29
High
$10.29
Low
$8.69
Mkt. cap
150.86M
Avg. vol.
242.58K
Volume
596.38K
52-wk high
$27.24
52-wk low
$8.69
EPS
-$2.88
Beta
0.45
Shares outstanding
15.56M
No. of employees
98
Open
$10.29
High
$10.29
Low
$8.69
Mkt. cap
150.86M
Avg. vol.
242.58K
Volume
596.38K
52-wk high
$27.24
52-wk low
$8.69
EPS
-$2.88
Beta
0.45
Shares outstanding
15.56M
No. of employees
98
News stories
From web sources and news partners
Profile
Prenetics is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer. Its subsidiary brands include CircleDNA, Insighta and IM8. Wikipedia
About Prenetics Global Ltd
CEO-
Employees98
Founded2014
Headquarters-
SectorHealth Care
IndustryHealth care provider
Analyst ratings
Based on 7 analysts giving stock ratings to PRE in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for PRE in the last 3 months.
Highest
Current $8.80
$54.00 (+513.64%)
Average
$40.33 (+358.30%)
Lowest
$30.00 (+240.91%)
Analyst
Recommendation
Action
Price target
Projected
Date
George Kelly
Roth MKM
Buy
Maintained
$30.00
+240.9%
11/19/2026
Jeff Van Sinderen
B. Riley Securities
Buy
Maintained
$31.00
+252.3%
11/19/2026
Ryan Meyers
Lake Street
Buy
Maintained
$35.00
+297.7%
11/18/2026
Kyle Bauser
Titan Partners
Buy
Initiated
$52.00
+490.9%
10/26/2026
Alexander Nowak
Lucid Capital
Buy
Initiated
$54.00
+513.6%
10/12/2026
Eric Des Lauriers
Craig-Hallum
Buy
Maintained
-
-
09/22/2026
Unknown Analyst
StoneX
Buy
Reiterated
$40.00
+354.5%
09/08/2026
Bill Sutherland
Benchmark Co.
Buy
Maintained
$40.00
+354.5%
07/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
36.56M
35.95M
46.49M
64.11M
Cost of goods sold
14.97M
12.67M
16.28M
-
Cost of revenue
14.97M
12.67M
16.28M
-
Research and development expenses
743.00K
1.44M
757.00K
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34.13M
31.55M
51.36M
56.31M
Operating expense
35.17M
32.15M
51.18M
56.15M
Total operating expenses
50.14M
44.82M
67.47M
79.54M
Operating income
-13.58M
-8.87M
-20.98M
-
Other non operating income
9.59M
-17.86M
9.28M
-7.23M
EBT including unusual items
-9.66M
-27.31M
-9.08M
-24.94M
EBT excluding unusual items
-3.87M
-26.74M
-11.71M
-
Income tax expense
38.00K
28.00K
5.00K
3.00K
Effective tax rate
-0.39%
-0.10%
-0.06%
-0.01%
Other operating expenses
297.00K
-840.00K
-941.00K
-
Net income
-7.50M
-23.10M
-8.98M
-
Net profit margin
-20.52%
-64.26%
-19.32%
-39.64%
Earnings per share
-0.19
-
-0.52
-0.92
Interest and investment income
1.20M
-
-
-
Interest expense
-45.00K
-9.00K
-13.00K
-783.00K
Net interest expenses
1.15M
-9.00K
-13.00K
-783.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.34M
-8.71M
-20.80M
-
Gain or loss from assets sale
-
-253.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps